Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
This week we welcome Dr Stanley Lewis the CEO and founder of A28 Therapeutics.
With a remarkable 25-year career in life sciences across clinical research, and drug development, he is a true leader in the field.
Formerly Chief Medical Officer at Ansun Biopharma, he successfully led late-stage trials, helped secure a $100 million Series B, and contributed to strategic in-licensing efforts.
In 2021, he founded A28, aiming to revolutionize global cancer care.
Enjoy and stay tuned
